The Future of Scientific Publishing in Oncology: Content Designed for Artificial Intelligence Ingestion

Abstract

Background:

The volume of oncology research continues to expand rapidly, creating an unsustainable cognitive burden for clinicians and researchers. Traditional scientific articles are written for human consumption and are poorly suited for machine processing, limiting the ability of artificial intelligence (AI) systems—such as large language models (LLMs) and multimodal AI tools—to extract and apply insights in real-time clinical settings.

Objective:

To propose a transformative framework for oncology publishing in which scientific content is structured and optimized for ingestion by AI systems, enabling personalized, interactive, and timely knowledge delivery.

Methods:

This article presents a narrative review of existing limitations in current publishing practices, examines technological enablers such as structured metadata, semantic annotations, and interoperability standards (e.g., HL7 FHIR, BioC), and highlights the role of FAIR (Findable, Accessible, Interoperable, Reusable) principles. The authors explore how AI-optimized content can integrate with clinical decision support tools and tumor boards, and propose incentives for publishers, editors, and authors to adopt machine-readable publication formats.

Results:

AI-optimized oncology content has the potential to enhance literature discoverability, reduce clinician burnout, and improve the utility of decision support systems. LLMs and multimodal AI models can summarize, personalize, and surface clinically relevant findings when publications are structured for algorithmic access. Emerging tools like APIs and plugins that connect machine-readable articles with electronic health records (EHRs) could enable just-in-time delivery of oncology knowledge tailored to individual patient cases.

Conclusions:

Redesigning oncology publications for AI consumption represents a critical evolution in biomedical communication. This shift requires alignment among stakeholders, the creation of validation frameworks, ethical oversight, and incentives for AI-readability. AI-enhanced publishing can help close the translational gap between research and clinical care, fostering more accessible, inclusive, and actionable oncology knowledge dissemination.